Filing metadata

Accession number
0000950170-24-022569
Form type
Form 3
Filer
Alaunos Therapeutics, Inc.
CIK
CIK 1107421
Filed
Feb 28, 2024
Reporting period
Feb 22, 2024
Description
Initial ownership

Explore SEC Filings Hub